LRMR

Larimar Therapeutics, Inc.NASDAQHealthcare

$4.79+5.43%ClosedMarket Cap: $409.9M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-20	Wedbush	—	Outperform	—
2026-02-25	Citigroup	—	Buy	—
2025-10-02	Oppenheimer	—	Outperform	—
2025-09-30	Baird	—	Outperform	—
2025-09-30	Wedbush	—	Outperform	—
2025-08-19	JMP Securities	—	Market Outperform	—
2025-06-25	Guggenheim	—	Buy	—
2025-06-24	Wedbush	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-1.54	$62.6M	5
Sun Dec 31	$-0.72	$161.4M	6
Mon Dec 31	$0.26	$313.5M	4
Tue Dec 31	$1.90	$555.7M	2